Related Experiment Videos
[Risk factors associated to upper gastrointestinal bleeding in non intensive care units]
Hernán A Pérez1, Andrés E Escudero Millán, Verónica Savio
1Servicio de Clínica Médica, Hospital Italiano de Córdoba, Argentina. hperez@hospital-italiano.com.ar
Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)
|October 11, 2005
Summary
Upper gastrointestinal bleeding (UGB) is a rare complication in non-intensive care unit hospitalizations. Diabetes and systemic inflammatory response syndrome (SIRS) are identified as potential risk factors, requiring increased hospital stays and transfusions.
Area of Science:
- Gastroenterology
- Internal Medicine
- Critical Care Medicine
Context:
- Upper gastrointestinal bleeding (UGB) is a well-documented complication in intensive care units (ICUs).
- However, its incidence and risk factors in non-ICU hospital settings are less understood.
- This study focuses on UGB in general clinical hospitalizations.
Purpose:
- To determine the incidence of UGB in non-ICU hospitalizations.
- To identify risk factors associated with UGB in this patient population.
- To analyze demographic data and known risk factors for UGB.
Summary:
- A case-control study analyzed patients with gastric ulcer disease presenting with melena and hematemesis.
- The incidence of UGB was found to be 2.8 per 10,000 discharges.
- UGB was associated with systemic inflammatory response syndrome (SIRS) (OR: 9.22) and diabetes (OR: 7.8).
Impact:
- Upper gastrointestinal bleeding during clinical hospitalization is a rare but significant complication.
- Patients experiencing UGB require longer hospital stays and a greater number of blood transfusions.
- Findings suggest a positive association between UGB and diabetes and SIRS, informing clinical risk assessment.